NICE has issued final draft guidance recommending Bayer’s finerenone for adults with symptomatic chronic heart failure and a left...
Lire la suiteThe Regen4HD study has launched the first clinical trial evaluating a pluripotent stem cell-derived neural stem cell therapy for...
Lire la suiteNovartis has secured European Commission approval for Itvisma, a one-time gene replacement therapy for a broad group of patients...
Lire la suiteAgomab Therapeutics is preparing to begin dosing patients in its phase 2b NOV-ERA study of ontunisertib for fibrostenosing Crohn’s...
Lire la suiteTeva Pharmaceutical Industries has submitted a New Drug Application to the U.S. Food and Drug Administration for ecopipam, an...
Lire la suiteAnocca has treated the first patients with its precision TCR T cell therapy, ANOC 001. NICE has recommended the...
Lire la suite